These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
272 related items for PubMed ID: 10804012
1. Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers. Waltregny D, Bellahcène A, de Leval X, Florkin B, Weidle U, Castronovo V. J Bone Miner Res; 2000 May; 15(5):834-43. PubMed ID: 10804012 [Abstract] [Full Text] [Related]
4. Bone sialoprotein stimulates focal adhesion-related signaling pathways: role in migration and survival of breast and prostate cancer cells. Gordon JA, Sodek J, Hunter GK, Goldberg HA. J Cell Biochem; 2009 Aug 15; 107(6):1118-28. PubMed ID: 19492334 [Abstract] [Full Text] [Related]
5. Expression of bone matrix proteins in human breast cancer: potential roles in microcalcification formation and in the genesis of bone metastases. Bellahcène A, Castronovo V. Bull Cancer; 1997 Jan 15; 84(1):17-24. PubMed ID: 9180854 [Abstract] [Full Text] [Related]
7. Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer. Bobinac D, Marić I, Zoricić S, Spanjol J, Dordević G, Mustać E, Fuckar Z. Croat Med J; 2005 Jun 15; 46(3):389-96. PubMed ID: 15861517 [Abstract] [Full Text] [Related]
8. CREB-1 and AP-1 transcription factors JunD and Fra-2 regulate bone sialoprotein gene expression in human breast cancer cells. Detry C, Lamour V, Castronovo V, Bellahcène A. Bone; 2008 Feb 15; 42(2):422-31. PubMed ID: 18088579 [Abstract] [Full Text] [Related]
10. Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. Bellahcène A, Merville MP, Castronovo V. Cancer Res; 1994 Jun 01; 54(11):2823-6. PubMed ID: 8187059 [Abstract] [Full Text] [Related]
11. Prostate stem cell antigen is overexpressed in prostate cancer metastases. Lam JS, Yamashiro J, Shintaku IP, Vessella RL, Jenkins RB, Horvath S, Said JW, Reiter RE. Clin Cancer Res; 2005 Apr 01; 11(7):2591-6. PubMed ID: 15814638 [Abstract] [Full Text] [Related]
13. Detection of bone sialoprotein in human breast cancer tissue and cell lines at both protein and messenger ribonucleic acid levels. Bellahcène A, Antoine N, Clausse N, Tagliabue E, Fisher LW, Kerr JM, Jarès P, Castronovo V. Lab Invest; 1996 Aug 01; 75(2):203-10. PubMed ID: 8765320 [Abstract] [Full Text] [Related]
14. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. Chung LW, Baseman A, Assikis V, Zhau HE. J Urol; 2005 Jan 01; 173(1):10-20. PubMed ID: 15592017 [Abstract] [Full Text] [Related]
15. Role of bone morphogenetic proteins in human prostate cancer pathogenesis and development of bone metastases: immunohistochemical study. Spanjol J, Djordjević G, Markić D, Klarić M, Fuckar D, Bobinac D. Coll Antropol; 2010 Apr 01; 34 Suppl 2():119-25. PubMed ID: 21302710 [Abstract] [Full Text] [Related]
16. The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients. Leeming DJ, Koizumi M, Byrjalsen I, Li B, Qvist P, Tankó LB. Cancer Epidemiol Biomarkers Prev; 2006 Jan 01; 15(1):32-8. PubMed ID: 16434583 [Abstract] [Full Text] [Related]
17. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer. Sharp JA, Sung V, Slavin J, Thompson EW, Henderson MA. Lab Invest; 1999 Jul 01; 79(7):869-77. PubMed ID: 10418827 [Abstract] [Full Text] [Related]
20. Type I collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy. Zissimopoulos A, Stellos K, Matthaios D, Petrakis G, Parmenopoulou V, Babatsikou F, Matthaiou E, Theodosiadou E, Hountis P, Koutis C. J BUON; 2009 Jul 01; 14(3):463-72. PubMed ID: 19810140 [Abstract] [Full Text] [Related] Page: [Next] [New Search]